eXoZymes Inc.
corporate_fare Company Profile
eXoZymes Inc. (NASDAQ:EXOZ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for EXOZ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for EXOZ spans 10-Q, FWP, S-1, 8-K.
Recent high-impact activity:
- eXoZymes Q3 10-Q: $7.49M Nine-Month Loss, Going Concern Reiterated, $3.26M Cash
- eXoZymes Prices $15M Unit Offering at Two Shares Plus One Five-Year Warrant, Pricing Still TBD
- eXoZymes Registers Up to $37.3M Underwritten Stock-and-Warrant Offering
- eXoZymes 10-Q: Going Concern Warning and Material Weakness Disclosed
- eXoZymes Secures Another $0.64M in Dilutive Unit Offering with Warrant Reset
Financial Snapshot
Short Interest & Short Volume
1.17 days to coverFINRA reported short interest of 17,877 shares in EXOZ as of the October 30, 2026 settlement, a 1.3% increase from the prior period — about 1.2 days to cover at its recent average daily volume. On November 20, 2026, 14.2% of EXOZ volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for EXOZ, detected from its recent SEC filings · based on capital-structure filings through 2026-11-09.
Offering Sized at $15 Million · Dilution Depends on Final Price
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →